Peer-Reviewed Journal Details
Mandatory Fields
Gasiorowski, K.,Brokos, B.,Echeverria, V.,Barreto, G. E.,Leszek, J.
2018
February
Mol Neurobiolmol Neurobiol
RAGE-TLR Crosstalk Sustains Chronic Inflammation in Neurodegeneration
Published
()
Optional Fields
Animals Humans Inflammation/*metabolism Nerve Degeneration/*metabolism Neurodegenerative Diseases/*metabolism Receptor for Advanced Glycation End Products/*metabolism Signal Transduction/*physiology Toll-Like Receptors/*metabolism
55
22
1463
1476
Chronic inflammatory reactions are consistenly present in neurodegeneration of Alzheimer type and are considered important factors that accelerate progression of the disease. Receptors of innate immunity participate in triggering and driving inflammatory reactions. For example, Toll-like receptors (TLRs) and receptor for advanced glycation end product (RAGE), major receptors of innate immunity, play a central role in perpetuation of inflammation. RAGE activation should be perceived as a primary mechanism which determines self-perpetuated chronic inflammation, and RAGE cooperation with TLRs amplifies inflammatory signaling. In this review, we highlight and discuss that RAGE-TLR crosstalk emerges as an important driving force of chronic inflammation in Alzheimer's disease.Chronic inflammatory reactions are consistenly present in neurodegeneration of Alzheimer type and are considered important factors that accelerate progression of the disease. Receptors of innate immunity participate in triggering and driving inflammatory reactions. For example, Toll-like receptors (TLRs) and receptor for advanced glycation end product (RAGE), major receptors of innate immunity, play a central role in perpetuation of inflammation. RAGE activation should be perceived as a primary mechanism which determines self-perpetuated chronic inflammation, and RAGE cooperation with TLRs amplifies inflammatory signaling. In this review, we highlight and discuss that RAGE-TLR crosstalk emerges as an important driving force of chronic inflammation in Alzheimer's disease.
1559-1182 (Electronic) 08
2017/02/09
http://www.ncbi.nlm.nih.gov/pubmed/28168427http://www.ncbi.nlm.nih.gov/pubmed/28168427
10.1007/s12035-017-0419-4
Grant Details